Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for Comments
The Food and Drug Administration (FDA, the Agency, or we) is hosting a hybrid public meeting to disc...
Publisher
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- September 25, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA, the Agency, or we) is hosting a hybrid public meeting to disc...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Pneumococcal vaccination programmes for infants, adults and individuals at increased clinical risk
Documents relating to the pneumococcal vaccination programmes for infants, adults and individuals at...
Easy Read guide to the pneumococcal vaccine
This Easy Read guide providing information on the pneumococcal vaccine.
HIV Action Plan monitoring and evaluation framework
Public health analysis of progress towards meeting the aims of the HIV Action Plan for England.
PERMA-HANDâ„¢ Silk Suture
Ethicon determined that PERMA-HANDâ„¢ Silk Suture subject to this recall (removal) was incorrectly man...